Interestingly, a low PI (<12.5% and <11.7%) of non-lymphoid CD34+ cells could predict with a great efficiency among MDS cases for the presence of anemia and thrombocytopenia, respectively (sensitivity of 63% and specificity of 80% in both cases; p≤0.02); likewise, a PI of NRBC <24.5% also predicted for anemia with a high specificity (sensitivity of 49%, specificity of 80%; p = 0.05), while a low PI of CD13hi/CD11b− maturing neutrophils efficiently identified patients with neutropenia (sensitivity of 65%, specificity of 70%; p = 0.03). This evidence concerns the gene CD34 and anemia.